Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gringeri

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Haematology|August 1, 1990
Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: implications for therapeutic strategiesG Finazzi, P M Mannucci, A Lazzarin, et al.
Thrombosis and Haemostasis|June 1, 1994
Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgeryE Santagostino, P M Mannucci, A Gringeri, et al.
The Journal of Infectious Diseases|November 14, 1997
Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressorsY J Zhang, C Fracasso, J R Fiore, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Continuous infusion in haemophilia: current practice in EuropeA Batorova, P Holme, A Gringeri, et al.
Transfusion|May 1, 1997
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilizationE Santagostino, P M Mannucci, A Gringeri, et al.
Journal of Medical Virology|January 1, 1989
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk childrenM G Rumi, R Romeo, M Bortolini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 12, 2002
Clinical outcomes and resource utilization associated with haemophilia care in EuropeW Schramm, S Royal, B Kroner, et al.
British Journal of Haematology|December 1, 1991
No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrateP M Mannucci, K A Bauer, A Gringeri, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infectionL S Fall, V Chams, H Le Coq, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoidH Le Buanec, A Lachgar, B Bizzini, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|August 1, 1990
Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: implications for therapeutic strategiesG Finazzi, P M Mannucci, A Lazzarin, et al.
Thrombosis and Haemostasis|June 1, 1994
Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgeryE Santagostino, P M Mannucci, A Gringeri, et al.
The Journal of Infectious Diseases|November 14, 1997
Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressorsY J Zhang, C Fracasso, J R Fiore, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Continuous infusion in haemophilia: current practice in EuropeA Batorova, P Holme, A Gringeri, et al.
Transfusion|May 1, 1997
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilizationE Santagostino, P M Mannucci, A Gringeri, et al.
Journal of Medical Virology|January 1, 1989
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk childrenM G Rumi, R Romeo, M Bortolini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 12, 2002
Clinical outcomes and resource utilization associated with haemophilia care in EuropeW Schramm, S Royal, B Kroner, et al.
British Journal of Haematology|December 1, 1991
No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrateP M Mannucci, K A Bauer, A Gringeri, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Evidence for an antiviral effect and interferon neutralizing capacity in human sera; variability and implications for HIV infectionL S Fall, V Chams, H Le Coq, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoidH Le Buanec, A Lachgar, B Bizzini, et al.
Pageof 13